Physician profile
Robert Ryan Taylor
NPI 1013135961
$1,640.38
in general payments reported to CMS, 2019-2025
11 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.95 · 2020: $159 · 2021: $60.18 · 2022: $476 · 2023: $693 · 2024: $93.46 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $718 · Gift: $169 · Consulting Fee: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $717.55 |
| Gift | $168.53 |
| Consulting Fee | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $337.06 | 2022-2023 | Opalescence |
| American Orthodontics Corporation | $331.29 | 2022-2025 | Empower-Metal, Radiance, Empower-Ceramic |
| Ormco Corporation | $327.33 | 2021-2023 | Damon 3, Insignia, D3-Mx |
| Align Technology, INC. | $176.09 | 2020-2023 | Invisalign, Itero |
| Nobel Biocare USA | $130.63 | 2023 | Nobelactive |
| 3m Company | $114.36 | 2019-2023 | Clarity Aligners, 3m, Transbond Supreme Lv |
| Kerr Corporation | $84.88 | 2020-2021 | |
| Patterson Companies, INC. | $71.42 | 2024 | |
| Solventum Corporation | $36.22 | 2024-2025 | Clarity Aligners, 3m Unitek Mbt, Clarity Advanced |
| Envista Holdings Corporation | $20.05 | 2025 | Damon Clear |
| Dentsply Sirona INC | $11.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.